MétaCan
Menu
← Back to cohort
Record W3210546731 · doi:10.1016/j.jtct.2021.10.013

Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation

2021· review· en· W3210546731 on OpenAlexaff
Rachel Phelan, Annie Im, Rebecca Hunter, Yoshihiro Inamoto, Maria Teresa Lupo Stanghellini, Alicia Rovó, Sherif M. Badawy, Linda J. Burns, Hesham Eissa, Hemant S. Murthy, Pinki Prasad, Akshay Sharma, Elizabeth Suelzer, Vaibhav Agrawal, Mahmoud Aljurf, Karen Baker, Grzegorz Basak, David Buchbinder, Zachariah DeFilipp, Lana Grković, Ajoy Dias, Hermann Einsele, Michael L. Eisenberg, Narendranath Epperla, Nosha Farhadfar, Arthur Flatau, Robert Peter Gale, Hildegard Greinix, Betty K. Hamilton, Shahrukh K. Hashmi, Peiman Hematti, Kareem Jamani, Dipnarine Maharaj, John Murray, Seema Naik, Sunita Nathan, Steven Z. Pavletic, Zinaida Perić, Dražen Pulanić, Richard Ross, Andrea Salonia, Isabel Sánchez‐Ortega, Bipin N. Savani, Tal Schechter, Ami J. Shah, Stephanie M. Smith, John A. Snowden, Amir Steinberg, Douglas Tremblay, Sarah C. Vij, Lauren M. Walker, Daniel Wolff, Jean A. Yared, Hélène Schoemans, André Tichelli

Bibliographic record

VenueTransplantation and Cellular Therapy · 2021
Typereview
Languageen
FieldMedicine
TopicHematopoietic Stem Cell Transplantation
Canadian institutionsSickKids FoundationHospital for Sick ChildrenUniversity of TorontoUniversity of Calgary
FundersNational Institute of Allergy and Infectious DiseasesOffice of Naval ResearchPharmacyclicsSanofi GenzymeTakeda OncologyU.S. Public Health ServiceGenentechHealth Resources and Services AdministrationNational Institutes of HealthMorphoSysDaiichi-SankyoSeagenOmeros CorporationAstellas PharmaAdaptive BiotechnologiesPfizerIncyteKiadis Pharmabluebird bioKyowa Kirin Pharmaceutical DevelopmentMedacJazz PharmaceuticalsCancer MoonshotMedical College of WisconsinStemCyteCareDxActinium PharmaceuticalsDaiichi Sankyo EuropeNational Cancer InstituteGilead SciencesMoonshot Research and Development ProgramSanofiKaryopharm TherapeuticsCelgeneNovartisGlaxoSmithKlineAmgenAccentureCSL BehringBristol-Myers SquibbAstraZenecaNational Heart, Lung, and Blood InstituteNovartis Pharmaceuticals CorporationAstellas Pharma US
KeywordsMedicineTransplantationDiseasePopulationSystematic reviewIntensive care medicineQuality of life (healthcare)Internal medicineMEDLINE

Abstract

fetched live from OpenAlex

Male-specific late effects after hematopoietic cell transplantation (HCT) include genital chronic graft-versus-host disease (GVHD), hypogonadism, sexual dysfunction, infertility, and subsequent malignancies, such as prostate, penile, and testicular cancer. These effects may be closely intertwined and cause prolonged morbidity and decreased quality of life after HCT. Here we provide a systematic review of male-specific late effects in a collaboration among transplantation physicians, endocrinologists, urologists, dermatologists, and sexual health professionals through the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. We used a systematic review methodology to summarize incidence, risk factors, screening, prevention, and treatment of these complications and provide consensus evidence-based recommendations for clinical practice and future research. Most of the evidence regarding male GVHD is still based on limited data, precluding strong therapeutic recommendations. Therefore, we recommend systematic screening for male genital GVHD regularly and reporting of cases to large registries to allow for a better understanding. Future research also should address treatment, given the little published evidence currently available. Male-specific endocrine consequences of HCT include hypogonadism, which also may affect bone health. Given the scanty evidence, current recommendations for hormone substitution and/or bone health treatment are based on similar principles as for the general population. Following HCT, sexual health decreases, and this topic should be addressed at regular intervals. Future studies should focus on interventional strategies to address sexual dysfunction. Infertility remains prevalent in patients having undergone myeloablative conditioning, warranting the offer of sperm preservation for all HCT candidates. Most studies on fertility rely on descriptive registry analysis and surveys, underscoring the importance of reporting post-HCT conception data to large registries. Although the quality of evidence is low, the development of cancer in male genital organs does not seem more prevalent in HCT recipients compared with the general population; however, subsequent malignancies in general seem to be more prevalent in males than in females, and special attention should be given to skin and oral mucosa. Male-specific late effects, which likely are more underreported than female-specific complications, should be systematically considered during the regular follow-up visits of male survivors who have undergone HCT. Care of patients with male-specific late effects warrants close collaboration between transplantation physicians and specialists from other involved disciplines. Future research should be directed toward better data collection on male-specific late effects and on studies about the interrelationships among these late effects, to allow the development of evidence-based effective management practices.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.010
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: Systematic review
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.009
Threshold uncertainty score0.018

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.010
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0070.008
Bibliometrics0.0050.005
Science and technology studies0.0000.000
Scholarly communication0.0020.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.074
GPT teacher head0.317
Teacher spread0.242 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations16
Published2021
Admission routes1
Has abstractno

Explore more

Same venueTransplantation and Cellular Therapy→Same topicHematopoietic Stem Cell Transplantation→French-language works237,207→